Stay updated with breaking news from Co ltd takeda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bleakley Financial Group LLC boosted its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 242,353 shares of the company’s stock after purchasing an additional 28,838 […] ....
Clean Yield Group decreased its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 4.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 510,522 shares of the company’s stock after selling 22,635 shares during the period. Takeda Pharmaceutical comprises about 3.1% of Clean Yield […] ....
Tsfg LLC decreased its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 12.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,746 shares of the company’s stock after selling 3,369 shares during the quarter. Tsfg LLC’s holdings […] ....
Five Oceans Advisors lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 14.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,720 shares of the company’s stock after selling 2,708 shares during the period. Five Oceans […] ....
Needham & Company LLC reissued their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report published on Monday morning, Benzinga reports. Needham & Company LLC currently has a $26.00 target price on the stock. Phathom Pharmaceuticals Price Performance Shares of NASDAQ:PHAT opened at $10.62 on Monday. Phathom Pharmaceuticals has a […] ....